PCV29 COST-EFFECTIVENESS OF REDUCTION IN CARDIOVASCULAR OUTCOMES WITH ATORVASTATIN IN PATIENTS WITH NORMAL TO MILDLY ELEVATED CHOLESTEROL LEVELS.TREATED FOR HYPERTENSION- THE ASCOT-LLA STUDY
Abstract
Authors
P Lindgren Buxton Mf T Kahan N Poulter B Dahlf P Sever H Wedel B Jnsson